Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 07-24-2017, 11:46 PM #1
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
8 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
8 yr Member
Default New research collaboration (Prana & Takeda) focussed on non-motor aspects of PD

"The research collaboration will investigate the ability of investigational compound PBT434 to mitigate gastrointestinal dysfunction; constipation, lowered colon motility and inflammation in mouse models, including an alpha-synuclein transgenic mouse."

"PBT434 is the first of a new generation of small molecules from the quinazolinone class of drugs that was specifically designed to block the accumulation and aggregation of alpha-synuclein and is expected to begin human testing in a Phase 1 trial later this year."

Press release from Prana:
Prana commences research collaboration with Takeda for the treatment of Parkinson’s disease gastrointestinal neuropathology | Prana Biotechnology

Open-access research paper:
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease | Acta Neuropathologica Communications | Full Text

Last edited by jeffreyn; 07-25-2017 at 07:03 AM.
jeffreyn is offline   Reply With QuoteReply With Quote

advertisement
Old 07-25-2017, 09:30 PM #2
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
8 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
8 yr Member
Default

As noted above, a human clinical trial (Phase I) of PBT434 is planned to commence later this year (focused on motor symptoms).

For those who would like some background information on PBT434, but don't have the time (or inclination) to read the research paper, the SoPD blog has a pretty-good write-up (IMHO):

Iron, life force, and Parkinson’s disease | The Science of Parkinson's disease
jeffreyn is offline   Reply With QuoteReply With Quote
Reply

Tags
alpha-synuclein, collaboration, mouse, pbt434, research


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Prana and Takeda Will Investigate PBT434 as Treatment for Gastrointestinal Damage in NewsBot Parkinson's News 0 07-24-2017 01:50 PM
MRI-guided focussed ultrasound for essential tremor Bogusia Parkinson's Disease 4 08-29-2016 01:02 PM
New Funding for Motor Neurone Disease Research BobbyB ALS News & Research 0 11-23-2007 11:16 AM


All times are GMT -5. The time now is 06:44 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.